- ►diabetesjournals.org S Lerche, B Brock, J Rungby, HE Bøtker, N … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE— Glucagon-like peptide-1 (GLP-1) has many effects on glucose
homeostasis, and GLP-1 receptors are broadly represented in many tissues
including the brain. Recent research in rodents suggests a protective ... Cited by 7 - Related articles - BL Direct - All 11 versions
MD Susanne Lerche, MD Birgitte Brock, JR … - Am Diabetes Assoc ¹Institute of Pharmacology, University of Aarhus, University Park 1240, 8000
Aarhus C ²Department of Endocrinology M, Aarhus University Hospital,
Noerrebrogade 44, 8000 Aarhus C ³PET-Center, Aarhus University Hospital ... Related articles
S Kalra, B Kalra, A Kumar - Recent Patents on Endocrine, Metabolic &# 38; …, 2009 - ingentaconnect.com Received: February 5, 2009; Accepted: February 26, 2009; Revised: March 17, 2009
Abstract: Much interest has focused on the newer incretin-based therapeutic
modalities for diabetes, especially GLP-1 analogues. While the ... Related articles
- ►gu.se [PDF] J Nyberg - gupea.ub.gu.se Abstract The hippocampus is an area of active cell proliferation and
neurogenesis within the adult mammalian brain. Adult neurogenesis is of great
importance for the brain, since it increases neuroplasticity and the ... Related articles - View as HTML - All 4 versions
RE Pratley - jhasim.com The incretin hormone, glucagon-like peptide- 1 (GLP-1) has well-characterized
effects on glu- cose homeostasis that make it an attractive new therapeutic
target for type 2 diabetes. In addition to its glucose-lowering properties, ... Related articles
- ►endojournals.org C Yamada, Y Yamada, K Tsukiyama, K Yamada … - Endocrinology, 2008 - Endocrine Soc Gastrointestinal hormones including gastric inhibitory polypeptide (GIP),
glucagon-like peptide (GLP)-1, and GLP-2 are secreted immediately after meal
ingestion, and GIP and GLP-2 have been shown to regulate bone turnover. We ... Cited by 9 - Related articles - BL Direct - All 3 versions
- ►nih.gov Y Li, TA Perry, MS Kindy, BK Harvey, D … - Proceedings of the National Academy of Sciences, 2009 - National Acad Sciences Glucagon-like peptide-1 (GLP-1) is an endogenous insulinotropic peptide secreted
from the gastrointestinal tract in response to food intake. It enhances
pancreatic islet β-cell proliferation and glucose-dependent insulin ... Cited by 1 - Related articles - All 10 versions
CH Jin, SY Chae, S Son, TH Kim, KA Um, YS … - Journal of Controlled Release, 2009 - Elsevier An orally active glucagon-like peptide-1 (GLP-1) formulation would have great
advantages over conventional injectable therapies for the treatment of diabetic
patients. Because GLP-1 absorption in the intestine is restricted by its ... Cited by 2 - Related articles - All 2 versions
K Lykkegaard, PJ Larsen, N Vrang, C Bock, T … - Schizophrenia Research, 2008 - Elsevier Female Sprague–Dawley rats were implanted with subcutaneous osmotic mini pumps
for delivery of olanzapine (1.75 mg/24 h) or vehicle for 28 days (n = 20). After
14 days, ten animals from each group were given liraglutide (0.2 mg/kg) or ... Cited by 3 - Related articles - All 24 versions
